Health / Medical Topics

    FGF Receptor Antagonist HGS1036

    A soluble fusion protein consisting of the extracellular domain of human fibroblast growth factor receptor 1 (FGFR1) fused to the Fc portion of human immunoglobulin G1 (IgG1) with potential antineoplastic and anti-angiogenic activities. FGFR1 receptor antagonist FP-1039 prevents FGFR ligands, such as FGF1, FGF2, FGF4, from binding to their cognate receptors, thereby inhibiting the activation of the related FGFR tyrosine kinases. Inhibition of FGFR1 by this agent may retard tumor cell proliferation and induce tumor cell death. FP-1039 may also inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis. FGFR1 is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cellular proliferation, differentiation, angiogenesis, and survival; most ligands that bind to FGFR1 also bind to the related receptors FGFR3 and FGFR4. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Encoded by human FRAG1 Gene, FGF Receptor Activating Protein 1 appears to be a 315-aa 36-kDa membrane-spanning protein whose function is not…
    Human FGD5 wild-type allele is located in the vicinity of 3p25.1 and is approximately 116 kb in length. This allele, which encodes…
    This gene plays a role in the reorganization of the actin cytoskeleton.
    Human FGD4 wild-type allele is located in the vicinity of 12p11.21 and is approximately 246 kb in length. This allele, which encodes…
    This gene plays a role in regulation of the actin cytoskeleton and cell shape.
    A profile-profile alignment algorithm that make structural predictions using sequence information.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact